Sunday, June 28, 2020

Yale researchers develop new genetic tool to analyze diseases

A team of researchers at the Yale School of Medicine have developed a new tool that opens the door for the genetic analysis of a wide range of human diseases.
The group has pioneered a way of understanding endogenous retroviruses, known as ERVs, which are remnants of retroviruses — a type of RNA virus that inserts its DNA into a host cell — that have integrated into the genome of the human body over millennia. This tool, called ERVmap, enables researchers to explore these pieces of retroviral RNA that have invaded the human genome but largely remain mysterious in terms of their function. 

Wednesday, June 17, 2020

The Practical Consideration of Poliovirus as an Oncolytic Virotherapy

The inauguration of novel treatment strategies into the clinical setting faces a number of hurdles. In addition to treatment efficacy and safety, acceptance by doctors and patients is paramount to the success of novel therapies. Although viruses are the cause of numerous infectious diseases, these acellular entities have been harnessed over the years to benefit mankind. Recently, a recombinant Poliovirus-Rhinovirus Chimera (PVSRIPO) has shown promise for the treatment of glioblastoma in clinical trials as well as other cancer types in animal model

Monday, June 1, 2020

The Future of Physical Therapy and Telehealth

Due to the recent pandemic, our health landscape has been quickly shifting. Healthcare professionals are now turning to virtual visits to treat their patients. This not only reduces the risk for themselves and their patients, but creates access and quality care for patients. Physical therapists have been no exception in adjusting their practices in order to accommodate patients through telemedicine. As a physical therapist, I have performed hundreds of these appointments. Here are the benefits of physical therapy telehealth services and the future it holds

Decreased Risk of Exposure

Compliance at Home

Combining In-Person